Showing results (141-150 of 313) with videos related to
Sort By:
Pageof 32
American Heart Journal|June 20, 2012
Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HFPaul J Hauptman, Peter J Schwartz, Michael R Gold, et al.Circulation|July 12, 2012
Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) studyMichael R Gold, Christophe Thébault, Cecilia Linde, et al.Heart Rhythm|December 3, 2014
The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE studyMichael R Gold, Claude Daubert, William T Abraham, et al.Heart Rhythm|December 21, 2011
Potential mechanisms underlying the effect of gender on response to cardiac resynchronization therapy: insights from the SMART-AV multicenter trialAlan Cheng, Michael R Gold, Alan D Waggoner, et al.Circulation. Arrhythmia and Electrophysiology|October 16, 2013
Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE)Michael R Gold, Jean-Claude Daubert, William T Abraham, et al.European Journal of Heart Failure|March 19, 2014
Long-term effectiveness of the combined minute ventilation and patient activity sensors as predictor of heart failure events in patients treated with cardiac resynchronization therapy: Results of the Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT device Trial (CLEPSYDRA) studyAngelo Auricchio, Michael R Gold, Josep Brugada, et al.Scientific Reports|September 14, 2017
Limitations of Qdot labelling compared to directly-conjugated probes for single particle tracking of B cell receptor mobilityLibin Abraham, Henry Y Lu, Rebeca Cardim Falcão, et al.Pacing and Clinical Electrophysiology : PACE|March 11, 2009
Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillatorsEva R Serber, Nancy J Finch, Robert B Leman, et al.European Heart Journal|January 31, 2012
Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trialChristophe Thébault, Erwan Donal, Catherine Meunier, et al.European Heart Journal|August 13, 2015
Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic reviewNeal A Chatterjee, Attila Roka, Steven A Lubitz, et al.Pageof 32